
|Articles|October 9, 2006
R.Ph.s can help reduce incidence of induced labor
Through-the-roof liability costs are convincing many hospitals to take measures to limit induced labor and the use of associated drugs, particularly the hormone oxytocin. "Inducing labor before 39 weeks places both mother and child at increased risk," said Kathy Connolly, assistant VP of risk management at Premier Inc., an alliance of 1,500 nonprofit hospitals.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Is it Safe for Birth Control Users to Go Years Without a Period?
2
Q&A: The Initiative Bringing Clinical Pharmacy Care to Underserved Patients’ Homes
3
Investigators Link Maternal Distress With Neurodevelopmental Delay Among Children
4
Investigators Evaluate Decline in Percentage of Patients With COPD Using Inhaled Corticosteroids
5




















































































































































